Literature DB >> 12435723

Combined effect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model.

J Yuste, A Fenoll, J Casal, M J Giménez, L Aguilar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12435723      PMCID： PMC132765          DOI： 10.1128/AAC.46.12.4043-4044.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin.

Authors:  J Yuste; M J Giménez; I Jado; A Fenoll; L Aguilar; J Casal
Journal:  J Antimicrob Chemother       Date:  2001-10       Impact factor: 5.790

2.  Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.

Authors:  J Casal; L Aguilar; I Jado; J Yuste; M J Giménez; J Prieto; A Fenoll
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model.

Authors:  J Yuste; I Jado; M J Giménez; L Aguilar; F Molero; A Fenoll; J Casal
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330
  3 in total
  6 in total

1.  Effects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant serotype 6B Streptococcus pneumoniae strain.

Authors:  D Tarragó; L Aguilar; M J Giménez; A Fenoll; J Casal
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.

Authors:  Elisa Ramos-Sevillano; Cinthya Rodríguez-Sosa; Roberto Díez-Martínez; María-José Giménez; Eduardo Olmedillas; Pedro García; Ernesto García; Lorenzo Aguilar; Jose Yuste
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

3.  Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model.

Authors:  Fabio Cafini; Jose Yuste; Maria-Jose Giménez; David Sevillano; Lorenzo Aguilar; Luis Alou; Elisa Ramos-Sevillano; Martha Torrico; Natalia González; Ernesto García; Pilar Coronel; Jose Prieto
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

Review 4.  Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.

Authors:  Mirian Domenech; Julio Sempere; Sara de Miguel; Jose Yuste
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

5.  Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus.

Authors:  Patricia Letrado; Bruno Corsini; Roberto Díez-Martínez; Noemí Bustamante; José E Yuste; Pedro García
Journal:  Future Microbiol       Date:  2018-09-21       Impact factor: 3.165

6.  Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains.

Authors:  Jose Manuel Tirado-Vélez; David Carreño; David Sevillano; Luis Alou; José Yuste; Adela G de la Campa
Journal:  Antibiotics (Basel)       Date:  2021-05-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.